Table III.
Groups | TTE, mean ± SD [days] | TGD (%) | MST [days] | ILS (%) |
---|---|---|---|---|
Control | 39 ±9 | – | 48 | – |
Vaccine | 47 ±10 | 21.2 | 50 | 4.2 |
Doxil | 60 ±4 | 53.8 | ND | ND |
Combination | 57 ±4 | 48.1 | ND* | ND |
TTE – time to reach end point, TGD – tumor growth delay, MST – median survival time, ILS – increase of life span.
Not defined; survival did not reach below 50% at the determined time point, then median survival could not be computed